Patrys Investor Newsletter | March 2023
0
Our latest Investor Newsletter is out now. Read the latest updates on progress towards our first in-human clinical trial of…
QUARTERLY ACTIVITIES REPORT & 4C
Patrys has today released its Quarterly Activities Report and Appendix 4C Quarterly Cash Flow report for the quarter ended 31…
Patrys receives R&D Tax Incentive Refund
Patrys has today announced that its wholly-owned subsidiary Nucleus Therapeutics Pty Ltd has received a $3.35 million R&D Tax Incentive…
Bioshares | November 22
Patrys has been featured in the latest edition of investor newsletter Bioshares. Bioshares highlights the progress the Company has made…
Insights Care Magazine | Interview with Dr James Campbell
Patrys CEO and MD, Dr James Campbell, was recently featured as one of Insights Care Magazine’s Top 10 Influential Healthcare…
VIDEO | ShareCafe Hidden Gems Webinar
Last week, Patrys CEO and MD, Dr James Campbell, presented at the ShareCafe Hidden Gems webinar, where he spoke about…
AGM Presentation
Patrys held its 2022 Annual General Meeting (AGM) this morning. The past financial year has been very productive for the…
Patrys Appoints Dr Charmaine Gittleson as Chairman
Patrys has today announced the appointment of Dr Charmaine Gittleson as the new Chairman of the Board of Directors. Dr…
VIDEO | AusBioInvest 2022
Patrys CEO and MD, Dr James Campbell, presented at the 2022 Australia Biotech Invest & Partnering Conference to update investors…
Quarterly Activities Report and 4C
Patrys has today released its Quarterly Activities Report and 4C for the quarter ended 30 September 2022. Key achievements include:…